| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | BRD-K34099515 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.02 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.02 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.02 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.4 | 0.02 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.03 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.03 |
| mRNA | ouabain | CTRPv2 | pan-cancer | AAC | -0.076 | 0.03 |